HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
UNC13D
unc-13 homolog D
Chromosome 17 Β· 17q25.1
NCBI Gene: 201294Ensembl: ENSG00000092929.14HGNC: HGNC:23147UniProt: Q70J99
93PubMed Papers
21Diseases
0Drugs
192Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingsmall GTPase bindingWeibel-Palade bodyregulation of mast cell degranulationFamilial hemophagocytic lymphohistiocytosisautoinflammatory syndromehereditary hemophagocytic lymphohistiocytosisneurodegenerative disease
✦AI Summary

UNC13D encodes Munc13-4, a critical regulator of cytotoxic granule exocytosis in immune cells, particularly cytotoxic T lymphocytes and natural killer (NK) cells 1. The protein plays essential roles in multiple steps of vesicle secretion, including granule biogenesis, tethering, and priming of cytotoxic vesicles at immunological synapses 1. UNC13D is required for the rapid and regulated secretion of secretory lysosomes, enabling immune cells to eliminate target cells through cytotoxic mechanisms 2. Pathogenic mutations in UNC13D cause familial hemophagocytic lymphohistiocytosis type 3 (FHL3), accounting for 30-40% of FHL cases 3. FHL3 patients present with defective cytotoxic function leading to antigen accumulation, resulting in severe systemic hyperinflammation characterized by fever, hepatosplenomegaly, cytopenias, and hemophagocytosis 34. UNC13D mutations are also associated with macrophage activation syndrome, where heterozygous variants contribute to defective lymphocyte cytolytic activity 5. The protein's dysfunction can manifest as isolated neuroinflammatory disease before systemic symptoms appear 6. Collectively, mutations in degranulation-related genes including UNC13D represent over 50% of genetic HLH cases, highlighting the critical importance of proper cytotoxic granule function in immune homeostasis 7.

Sources cited
1
UNC13D encodes Munc13-4 protein involved in cytotoxic granule secretion and vesicle biogenesis, tethering, and priming
PMID: 39469717
2
UNC13D mutations cause FHL3, accounting for 30-40% of FHL cases with defective cytotoxic function
PMID: 32679608
3
UNC13D regulates secretory lysosome release in immune cells
PMID: 16877763
4
UNC13D is one of the familial HLH genes causing severe systemic hyperinflammation
PMID: 32107531
5
UNC13D heterozygous mutations are linked to macrophage activation syndrome with defective cytolytic activity
PMID: 30774631
6
UNC13D mutations can present as isolated neuroinflammatory disease before systemic HLH
PMID: 32638196
7
Degranulation defect genes including UNC13D represent >50% of genetic HLH cases
PMID: 32542393
Disease Associationsβ“˜21
Familial hemophagocytic lymphohistiocytosisOpen Targets
0.79Strong
autoinflammatory syndromeOpen Targets
0.54Moderate
hereditary hemophagocytic lymphohistiocytosisOpen Targets
0.38Weak
neurodegenerative diseaseOpen Targets
0.37Weak
cardiovascular diseaseOpen Targets
0.27Weak
response to statinOpen Targets
0.20Weak
genetic disorderOpen Targets
0.19Weak
coronary artery diseaseOpen Targets
0.19Weak
HypercholesterolemiaOpen Targets
0.14Weak
metabolic diseaseOpen Targets
0.12Weak
asthmaOpen Targets
0.09Suggestive
adult onset asthmaOpen Targets
0.08Suggestive
Von Willebrand diseaseOpen Targets
0.07Suggestive
Glanzmann thrombasthenia 1Open Targets
0.07Suggestive
Rare hemorrhagic disorder due to a constitutional platelet anomalyOpen Targets
0.06Suggestive
autosomal dominant macrothrombocytopeniaOpen Targets
0.06Suggestive
thrombocytopenia 7Open Targets
0.06Suggestive
isolated agammaglobulinemiaOpen Targets
0.06Suggestive
activated PI3K-delta syndromeOpen Targets
0.06Suggestive
cancerOpen Targets
0.06Suggestive
Hemophagocytic lymphohistiocytosis, familial, 3UniProt
Pathogenic Variants192
NM_199242.3(UNC13D):c.2037_2038insG (p.Arg680fs)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 680
NM_199242.3(UNC13D):c.766C>T (p.Arg256Ter)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided|UNC13D-related disorder|Autoinflammatory syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 256
NM_199242.3(UNC13D):c.177_178del (p.Tyr61fs)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 61
NM_199242.3(UNC13D):c.118-308C>TPathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided|Familial hemophagocytic lymphohistiocytosis
β˜…β˜…β˜†β˜†2026
NM_199242.3(UNC13D):c.2346_2349del (p.Arg782fs)Pathogenic
not provided|Familial hemophagocytic lymphohistiocytosis 3|Autoinflammatory syndrome|Familial hemophagocytic lymphohistiocytosis
β˜…β˜…β˜†β˜†2026β†’ Residue 782
NM_199242.3(UNC13D):c.551G>A (p.Trp184Ter)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 184
NM_199242.3(UNC13D):c.322-2A>TPathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2026
NM_199242.3(UNC13D):c.1229_1230dup (p.Arg411fs)Pathogenic
Autoinflammatory syndrome|Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025β†’ Residue 411
NM_199242.3(UNC13D):c.1847A>G (p.Glu616Gly)Pathogenic
not provided|Familial hemophagocytic lymphohistiocytosis|Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025β†’ Residue 616
NM_199242.3(UNC13D):c.627del (p.Val210fs)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025β†’ Residue 210
NM_199242.3(UNC13D):c.247C>T (p.Arg83Ter)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|Autoinflammatory syndrome|Familial hemophagocytic lymphohistiocytosis
β˜…β˜…β˜†β˜†2025β†’ Residue 83
NM_199242.3(UNC13D):c.753+1G>TPathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided|Familial hemophagocytic lymphohistiocytosis
β˜…β˜…β˜†β˜†2025
NM_199242.3(UNC13D):c.1389+1G>APathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome|Colon adenocarcinoma
β˜…β˜…β˜†β˜†2025
NM_199242.3(UNC13D):c.1240C>T (p.Arg414Cys)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided|Familial hemophagocytic lymphohistiocytosis
β˜…β˜…β˜†β˜†2025β†’ Residue 414
NM_199242.3(UNC13D):c.2695C>T (p.Arg899Ter)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3|not provided|Autoinflammatory syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 899
NC_000017.11:g.75834356_75834365delinsTCGGACAAGGTAPathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025
NM_199242.3(UNC13D):c.118-307G>APathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025
NM_199242.3(UNC13D):c.2831-13G>APathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025
NM_199242.3(UNC13D):c.1848+1G>APathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025
NM_199242.3(UNC13D):c.817C>T (p.Arg273Ter)Pathogenic
Familial hemophagocytic lymphohistiocytosis 3
β˜…β˜…β˜†β˜†2025β†’ Residue 273
View on ClinVar β†—
Related Genes
RAB27BProtein interaction90%STX19Protein interaction87%FHL2Protein interaction84%STX11Protein interaction79%STXBP2Protein interaction78%AP3B1Protein interaction72%
Tissue Expression6 tissues
Lung
100%
Bone Marrow
94%
Ovary
32%
Liver
21%
Heart
15%
Brain
1%
Gene Interaction Network
Click a node to explore
UNC13DRAB27BSTX19FHL2STX11STXBP2AP3B1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q70J99
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.92LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.79 [0.68–0.92]
RankingsWhere UNC13D stands among ~20K protein-coding genes
  • #5,170of 20,598
    Most Researched93
  • #364of 5,498
    Most Pathogenic Variants192 Β· top 10%
  • #8,485of 17,882
    Most Constrained (LOEUF)0.92
Genes detectedUNC13D
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Pediatric hemophagocytic lymphohistiocytosis.
PMID: 32107531
Blood Β· 2020
1.00
2
The Immunology of Macrophage Activation Syndrome.
PMID: 30774631
Front Immunol Β· 2019
0.90
3
Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders.
PMID: 32542393
Blood Adv Β· 2020
0.80
4
Functional role of UNC13D in immune diseases and its therapeutic applications.
PMID: 39469717
Front Immunol Β· 2024
0.70
5
Clinical, immunological and genetic findings in patients with UNC13D deficiency (FHL3): A systematic review.
PMID: 32679608
Pediatr Allergy Immunol Β· 2021
0.60